Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: A retrospective study of 34 eyes

Acta Ophthalmologica

Volumn 90, Issue 4, 2012, Pages 357-361

  Puche, Nathalie ^a   Glacet, Agnès ^a   Mimoun, Gérard ^a   Zourdani, Alain ^a   Coscas, Gabriel ^a   Soubrane, Gisèle ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

anti VEGF therapy; branch retinal vein occlusion; central retinal vein occlusion; intravitreous injection; macular oedema; ranibizumab

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; BRANCH RETINA VEIN OCCLUSION; CENTRAL RETINA THICKNESS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; IRIS RUBEOSIS; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA TEAR; RETINA VEIN OCCLUSION; RETREATMENT; RETROSPECTIVE STUDY; SYSTEMIC DISEASE; UVEITIS; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84861601308     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.01913.x     Document Type: Article

References (22)

1. Algvere PV, von Wendt G, Gudmundsson J, Seregard S, &, Kvanta A, (2009): Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin). Acta Ophthalmol [Epub ahead of print].
2. Angulo Bocco MC, Glacet-Bernard A, Zourdani A, Coscas G, &, Soubrane G, (2008): [Intravitreous injection: retrospective study on 2028 injections and their side effects]. J Fr Ophtalmol 31: 693-698.
3. Branch Vein Occlusion Study Group (1984): Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 98: 271-282.
4. Campochiaro PA, Hafiz G, Shah SM, et al., (2008): Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 16: 791-799.
5. Central Vein Occlusion Study Group (1995): Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 102: 1425-1433.
6. Central Vein Occlusion Study Group (1997): Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 115: 486-491.
7. Chung EJ, Hong YT, Lee SC, Kwon OW, &, Koh HJ, (2008): Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246: 1241-1247.
8. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, &, Samama MM, (1996): Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103: 551-560.
9. Goff MJ, Jumper JM, Yang SS, Fu AD, Johnson RN, McDonald HR, &, Ai E, (2006): Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Retina 26: 896-901.
10. Heier JS, Antoszyk AN, Pavan PR, et al., (2006): Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology 113: 633. e631-634.
11. Jaissle GB, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, &, Szurman P, (2009): One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247: 27-33.
12. Kim KS, Chang HR, &, Song S, (2008): Ischaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion. Acta Ophthalmol 86: 925-927.
13. Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W, &, Schmidt-Erfurth U, (2008): Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92: 518-522.
14. Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, &, Adamis AP, (2000): Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156: 1733-1739.
15. Noma H, Funatsu H, Yamasaki M, et al., (2005): Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140: 256-261.
16. Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H, &, Mishima HK, (2006): Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244: 309-315.
17. Pieramici DJ, Rabena M, Castellarin AA, et al., (2008): Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. Ophthalmology 115: e47-e54.
18. Rensch F, Jonas JB, &, Spandau UH, (2009): Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion. Acta Ophthalmol 87: 77-81.
19. Shima C, Sakaguchi H, Gomi F, et al., (2008): Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86: 372-376.
20. Shimura M, Nakazawa T, Yasuda K, Kunikata H, Shiono T, &, Nishida K, (2008): Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol 86: 377-384.
21. Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, &, Klein R, (2009): Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 147: 298-306.
22. Williamson TH, &, O'Donnell A, (2005): Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 139: 860-866.